Page | (sequential) | | | | (alphabetic) | Top |
---|
| | |
- Alternative Formats (Word, et al.)
- Accounting Treatment
- Affiliate Agreements
- Agouron
- Agouron Selected Financial Data
- (a) Organization
- (a) Organization, Standing and Power; Subsidiaries
- Appraisal Rights
- (a) Representations and Warranties
- Article Ii Exchange of Certificates
- Article Iii Representations and Warranties
- Article I the Merger
- Article Iv Covenants Relating to Conduct of Business
- Article V Additional Agreements
- Article Vi Conditions Precedent
- Article Viii General Provisions
- Article Vii Termination and Amendment
- (a) Stockholder Approval
- Authorized Capital Stock
- Background of the Merger
- (b) Capital Structure
- (b) Corporate Authorization
- (b) No Injunctions or Restraints, Illegality
- Board of Directors
- (b) Performance of Obligations of Agouron
- (b) Performance of Obligations of Warner-Lambert
- (c) Authority; No Conflicts
- Certain Legal Proceedings
- (c) HSR Act
- Closing
- (c) Non-Contravention
- Common Stock
- Companies, The
- Comparative Per Share Data
- Comparison of Shareholder Rights
- Conditions to the Merger
- (c) Tax Opinion
- Description of Warner-Lambert Capital Stock
- Dissenters' Rights
- (d) No Business Activities
- (d) No Material Adverse Change
- (d) NYSE Listing
- (d) Reports and Financial Statements
- (e) Effectiveness of the Form S-4
- Effective Time
- Effect of Stock Option Agreement
- (e) Information Supplied
- (e) Rights Agreement
- Exhibits and Financial Statement Schedules
- Expenses
- Experts
- (f) Board Approval
- (f) Dissenting Agouron Shares
- Form S-4
- (f) Pooling
- General
- General; Date, Time and Place
- (g) Litigation; Compliance with Laws
- (g) Vote Required
- (h) Absence of Certain Changes or Events
- (h) Litigation; Compliance with Laws
- (i) Absence of Certain Changes or Events
- (i) Environmental Matters
- Indemnification and Insurance
- Indemnification of Directors and Officers
- (j) Brokers or Finders
- (j) Environmental Matters
- (k) Intellectual Property
- (k) Opinion of Warner-Lambert Financial Advisor
- (l) Accounting Matters
- Legal Matters
- Limitation of Profit
- Long-term liabilities
- (l) Rights Agreement
- Market Price and Dividend Data
- Material Federal Income Tax Consequences
- (m) Brokers or Finders
- Merger Agreement, The
- Merger, The
- (n) Opinion of Agouron Financial Advisor
- No Solicitation of Acquisition Transactions
- (o) Accounting Matters
- Opinion of PaineWebber
- Preferred Stock
- Proxies
- (p) Taxes
- Purposes of the Special Meeting
- (q) Certain Contracts
- Reasons for the Merger; Recommendation of the Agouron Board
- Recommendation of the Agouron Board
- Registration Rights
- Regulatory Approvals
- (r) Employee Benefit Plans
- Rights Agreement
- Right to Call Special Meetings
- Risk Factors
- Selected Comparable Mergers and Acquisitions Analysis
- Selected Historical Financial Data
- (s) Labor Matters
- Special Meeting, The
- Stock Exchange Listing
- Stock Exchange Quotation
- Stock Option Agreement
- Substitute Option
- Summary
- Table of Contents
- (t) Affiliate Transactions
- Termination, Amendment or Waiver
- Termination Fee
- Terms of the Option
- The Companies
- The Merger
- The Merger Agreement
- The Special Meeting
- Transfer Agent and Registrar
- (u) Material Contract Defaults
- Undertakings
- (v) Insurance
- Warner-Lambert
- Warner-Lambert pro forma combined
- Warner-Lambert Pro Forma Combined Selected Financial Data
- Warner-Lambert Unaudited Pro Forma Condensed Combined Financial Statements
- Where You Can Find More Information
- (w) Year 2000 Compliance
- (x) Supply
- (y) Investigational Compounds and Viracept
- (z) Generic Drug Enforcement Act
- 1.10 Agouron Stock Options
- 1.11 Certain Adjustments
- 1.2 Closing
- 1.3 Effective Time
- 1.4 Effects of the Merger
- 1.5 Certificate of Incorporation
- 1.6 By-Laws
- 1.7 Officers and Directors of Surviving Corporation
- 1.8 Effect of Merger on Capital Stock
- 1.9 Dissenting Agouron Common Shares
- 2.10 Withholding Rights
- 2.11 Further Assurances
- 2.12 Stock Transfer Books
- 2.1 Exchange Fund
- 2.2 Exchange Procedures
- 2.3 Distributions with Respect to Unexchanged Shares
- 2.4 No Further Ownership Rights in Agouron Common Stock
- 2.5 No Fractional Shares of Warner-Lambert Common Stock
- 2.6 Termination of Exchange Fund
- 2.7 No Liability
- 2.8 Investment of the Exchange Fund
- 2.9 Lost Certificates
- 3.1 Representations and Warranties of Warner-Lambert
- 3.2 Representations and Warranties of Agouron
- 3.3 Representations and Warranties of Warner-Lambert and Merger Sub
- 4.1 Conduct of Business of Agouron Pending the Merger
- 4.2 Conduct of Business of Warner-Lambert Pending the Merger
- 4.3 Governmental Filings
- 4.4 Control of Other Party's Business
- 5.10 Listing of Shares of Warner-Lambert Common Stock
- 5.11 Affiliates
- 5.12 Amendment to the Rights Agreement
- 5.13 Divisional Stock Proposal
- 5.1 Preparation of Form S-4 and the Proxy Statement; Stockholders Meeting
- 5.2. Accountant's Letters
- 5.3 Access to Information
- 5.4 Reasonable Best Efforts
- 5.5 No Solicitation of Transactions
- 5.6 Employee Benefits Matters
- 5.7 Directors' and Officers' Indemnification and Insurance
- 5.8 Notification of Certain Matters
- 5.9 Public Announcements
- 6.1 Conditions to Each Party's Obligation to Effect the Merger
- 6.2 Additional Conditions to Obligations of Warner-Lambert and Merger Sub
- 6.3 Additional Conditions to Obligations of Agouron
- 7.1 Termination
- 7.2 Effect of Termination
- 7.3 Fees and Expenses
- 7.4 Amendment
- 7.5 Extension; Waiver
- 8.10 Enforcement
- 8.11 Definitions
- 8.1 Non-Survival of Representations, Warranties and Agreements
- 8.2 Notices
- 8.3 Interpretation
- 8.4 Counterparts
- 8.5 Entire Agreement; No Third Party Beneficiaries
- 8.6 Governing Law
- 8.7 Severability
- 8.8 Assignment
- 8.9 Submission to Jurisdiction; Waivers
|
1 | 1st Page - Filing Submission
|
" | Form S-4
|
4 | Table of Contents
|
9 | Summary
|
11 | The Merger
|
14 | Selected Historical Financial Data
|
15 | Agouron Selected Financial Data
|
16 | Warner-Lambert Pro Forma Combined Selected Financial Data
|
" | Warner-Lambert pro forma combined
|
17 | Comparative Per Share Data
|
18 | Market Price and Dividend Data
|
" | Agouron
|
" | Warner-Lambert
|
20 | Risk Factors
|
22 | The Special Meeting
|
" | General; Date, Time and Place
|
" | Purposes of the Special Meeting
|
" | Recommendation of the Agouron Board
|
23 | Proxies
|
24 | Dissenters' Rights
|
" | The Companies
|
25 | General
|
" | Background of the Merger
|
27 | Reasons for the Merger; Recommendation of the Agouron Board
|
28 | Opinion of PaineWebber
|
33 | Selected Comparable Mergers and Acquisitions Analysis
|
35 | Material Federal Income Tax Consequences
|
37 | Accounting Treatment
|
" | Regulatory Approvals
|
38 | Stock Exchange Quotation
|
39 | Certain Legal Proceedings
|
42 | The Merger Agreement
|
" | Closing
|
" | Effective Time
|
43 | Conditions to the Merger
|
47 | No Solicitation of Acquisition Transactions
|
48 | Affiliate Agreements
|
49 | Termination, Amendment or Waiver
|
50 | Termination Fee
|
51 | Expenses
|
" | Indemnification and Insurance
|
52 | Stock Option Agreement
|
" | Terms of the Option
|
53 | Registration Rights
|
54 | Substitute Option
|
" | Limitation of Profit
|
" | Effect of Stock Option Agreement
|
55 | Warner-Lambert Unaudited Pro Forma Condensed Combined Financial Statements
|
58 | Long-term liabilities
|
60 | Description of Warner-Lambert Capital Stock
|
" | Authorized Capital Stock
|
" | Common Stock
|
" | Preferred Stock
|
61 | Transfer Agent and Registrar
|
" | Stock Exchange Listing
|
" | Rights Agreement
|
" | Comparison of Shareholder Rights
|
62 | Right to Call Special Meetings
|
64 | Appraisal Rights
|
65 | Legal Matters
|
" | Experts
|
" | Where You Can Find More Information
|
71 | 1.5 Certificate of Incorporation
|
73 | Article I the Merger
|
" | 1.2 Closing
|
" | 1.3 Effective Time
|
" | 1.4 Effects of the Merger
|
" | 1.6 By-Laws
|
" | 1.7 Officers and Directors of Surviving Corporation
|
74 | 1.8 Effect of Merger on Capital Stock
|
" | 1.9 Dissenting Agouron Common Shares
|
" | 1.10 Agouron Stock Options
|
75 | 1.11 Certain Adjustments
|
" | Article Ii Exchange of Certificates
|
" | 2.1 Exchange Fund
|
" | 2.2 Exchange Procedures
|
76 | 2.3 Distributions with Respect to Unexchanged Shares
|
" | 2.4 No Further Ownership Rights in Agouron Common Stock
|
" | 2.5 No Fractional Shares of Warner-Lambert Common Stock
|
77 | 2.6 Termination of Exchange Fund
|
" | 2.7 No Liability
|
" | 2.8 Investment of the Exchange Fund
|
" | 2.9 Lost Certificates
|
" | 2.10 Withholding Rights
|
78 | 2.11 Further Assurances
|
" | 2.12 Stock Transfer Books
|
" | Article Iii Representations and Warranties
|
" | 3.1 Representations and Warranties of Warner-Lambert
|
" | (a) Organization, Standing and Power; Subsidiaries
|
79 | (b) Capital Structure
|
80 | (c) Authority; No Conflicts
|
81 | (d) Reports and Financial Statements
|
" | (e) Information Supplied
|
82 | (f) Board Approval
|
" | (g) Litigation; Compliance with Laws
|
" | (h) Absence of Certain Changes or Events
|
83 | (i) Environmental Matters
|
" | (j) Brokers or Finders
|
" | (k) Opinion of Warner-Lambert Financial Advisor
|
" | (l) Accounting Matters
|
" | 3.2 Representations and Warranties of Agouron
|
87 | (g) Vote Required
|
" | (h) Litigation; Compliance with Laws
|
" | (i) Absence of Certain Changes or Events
|
" | (j) Environmental Matters
|
88 | (k) Intellectual Property
|
89 | (l) Rights Agreement
|
" | (m) Brokers or Finders
|
" | (n) Opinion of Agouron Financial Advisor
|
" | (o) Accounting Matters
|
" | (p) Taxes
|
90 | (q) Certain Contracts
|
91 | (r) Employee Benefit Plans
|
92 | (s) Labor Matters
|
" | (t) Affiliate Transactions
|
" | (u) Material Contract Defaults
|
93 | (v) Insurance
|
" | (w) Year 2000 Compliance
|
" | (x) Supply
|
" | (y) Investigational Compounds and Viracept
|
" | (z) Generic Drug Enforcement Act
|
" | 3.3 Representations and Warranties of Warner-Lambert and Merger Sub
|
" | (a) Organization
|
" | (b) Corporate Authorization
|
94 | (c) Non-Contravention
|
" | (d) No Business Activities
|
" | Article Iv Covenants Relating to Conduct of Business
|
" | 4.1 Conduct of Business of Agouron Pending the Merger
|
96 | 4.2 Conduct of Business of Warner-Lambert Pending the Merger
|
97 | 4.3 Governmental Filings
|
" | 4.4 Control of Other Party's Business
|
" | Article V Additional Agreements
|
" | 5.1 Preparation of Form S-4 and the Proxy Statement; Stockholders Meeting
|
98 | 5.2. Accountant's Letters
|
99 | 5.3 Access to Information
|
" | 5.4 Reasonable Best Efforts
|
100 | 5.5 No Solicitation of Transactions
|
101 | 5.6 Employee Benefits Matters
|
103 | 5.7 Directors' and Officers' Indemnification and Insurance
|
" | 5.8 Notification of Certain Matters
|
" | 5.9 Public Announcements
|
" | 5.10 Listing of Shares of Warner-Lambert Common Stock
|
104 | 5.11 Affiliates
|
" | 5.12 Amendment to the Rights Agreement
|
" | 5.13 Divisional Stock Proposal
|
" | Article Vi Conditions Precedent
|
" | 6.1 Conditions to Each Party's Obligation to Effect the Merger
|
" | (a) Stockholder Approval
|
" | (b) No Injunctions or Restraints, Illegality
|
105 | (c) HSR Act
|
" | (d) NYSE Listing
|
" | (e) Effectiveness of the Form S-4
|
" | (f) Pooling
|
" | 6.2 Additional Conditions to Obligations of Warner-Lambert and Merger Sub
|
" | (a) Representations and Warranties
|
" | (b) Performance of Obligations of Agouron
|
106 | (c) Tax Opinion
|
" | (d) No Material Adverse Change
|
" | (e) Rights Agreement
|
" | (f) Dissenting Agouron Shares
|
" | 6.3 Additional Conditions to Obligations of Agouron
|
" | (b) Performance of Obligations of Warner-Lambert
|
107 | Article Vii Termination and Amendment
|
" | 7.1 Termination
|
108 | 7.2 Effect of Termination
|
" | 7.3 Fees and Expenses
|
109 | 7.4 Amendment
|
" | 7.5 Extension; Waiver
|
" | Article Viii General Provisions
|
" | 8.1 Non-Survival of Representations, Warranties and Agreements
|
" | 8.2 Notices
|
110 | 8.3 Interpretation
|
" | 8.4 Counterparts
|
" | 8.5 Entire Agreement; No Third Party Beneficiaries
|
111 | 8.6 Governing Law
|
" | 8.7 Severability
|
" | 8.8 Assignment
|
" | 8.9 Submission to Jurisdiction; Waivers
|
" | 8.10 Enforcement
|
112 | 8.11 Definitions
|
126 | Board of Directors
|
135 | Item 20. Indemnification of Directors and Officers
|
136 | Item 21. Exhibits and Financial Statement Schedules
|
137 | Item 22. Undertakings
|